Innealta Capital’s Vera Therapeutics VERA Stock Holding History

Innealta Capital’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-42	Closed	-$1.52K	–	1625
2024 Q2	$1.52K	Buy	+42	New	+$1.67K	﹤0.01%	1185

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Innealta Capital's VERA Position: Q3 2024 in Review

Innealta Capital sold out of Vera Therapeutics (VERA) in Q3 2024, closing a stake of 42 shares — an estimated $1.52K sold.

Innealta Capital first reported a position in VERA in Q2 2024 and held it in 1 quarter. The position peaked at $1.52K in Q2 2024. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

Innealta Capital reported no remaining Vera Therapeutics position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 42 Vera Therapeutics shares in Q3 2024, an estimated $1.52K.
Innealta Capital first reported a position in Vera Therapeutics in Q2 2024 and held it in 1 quarter.
Innealta Capital's Vera Therapeutics position peaked at $1.52K in Q2 2024.
173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.